Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKaradağ Sarı, Ebru
dc.contributor.authorBakır, Buket
dc.contributor.authorAydın, B. D.
dc.contributor.authorSözmen, Mahmut
dc.date.accessioned2022-05-11T14:42:26Z
dc.date.available2022-05-11T14:42:26Z
dc.date.issued2014
dc.identifier.issn1052-0295
dc.identifier.urihttps://doi.org/10.3109/10520295.2013.844274
dc.identifier.urihttps://hdl.handle.net/20.500.11776/9377
dc.description.abstractCommercial probiotic capsules that contain probiotic bacteria, kefir, koumiss and yogurt contain beneficial microorganisms that affect cholesterol levels and immune response, and are used for treatment of some diseases. We investigated using immunohistochemistry the effects of kefir, koumiss, yogurt and a commercial probiotic formulation on the expression levels of peroxisome proliferator-Activated receptor-? (PPAR?) and peroxisome proliferator-Activated receptor-?/? (PPAR-?/?), which are members of the nuclear steroid hormone receptor superfamily in mouse kidney. Mice were assigned to five groups: group 1, commercial probiotic capsules; group 2, kefir; group 3, koumiss; group 4, yogurt; group 5, control. After oral administration for 15 days, body weights were recorded and kidney tissue samples were obtained. Hematoxylin & eosin staining and the streptavidin-biotin peroxidase complex (ABC) method were applied to tissue sections to examine histology and to determine the localization of PPAR? and PPAR-?/? in the kidneys. We found that the weights of the mice in the kefir, koumiss, yogurt and commercial probiotic capsules groups were increased compared to controls. No differences in kidney histology were observed in any of the experimental groups. Kefir, koumiss, yogurt and the commercial probiotic preparation increased PPAR? and PPAR-?/? expressions. © 2014 The Biological Stain Commission.en_US
dc.description.sponsorshipThis Project was supported by the Commission for the Scientific Research Projects of Kafkas University, project number 2012-VF-5 Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.en_US
dc.language.isoengen_US
dc.publisherInforma Healthcareen_US
dc.identifier.doi10.3109/10520295.2013.844274
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectKefiren_US
dc.subjectKoumissen_US
dc.subjectPPAR-?/?en_US
dc.subjectPPAR?en_US
dc.subjectProbioticsen_US
dc.subjectYogurten_US
dc.subjectperoxisome proliferator activated receptor deltaen_US
dc.subjectperoxisome proliferator activated receptor gammaen_US
dc.subjectprobiotic agenten_US
dc.subjectyoghurten_US
dc.subjectanimalen_US
dc.subjectcomparative studyen_US
dc.subjectdairy producten_US
dc.subjectkidneyen_US
dc.subjectmaleen_US
dc.subjectmetabolismen_US
dc.subjectmouseen_US
dc.subjectoral drug administrationen_US
dc.subjectAdministration, Oralen_US
dc.subjectAnimalsen_US
dc.subjectCultured Milk Productsen_US
dc.subjectKidneyen_US
dc.subjectMaleen_US
dc.subjectMiceen_US
dc.subjectPPAR deltaen_US
dc.subjectPPAR gammaen_US
dc.subjectPPAR-betaen_US
dc.subjectProbioticsen_US
dc.subjectYogurten_US
dc.titleThe effects of kefi r, koumiss, yogurt and commercial probiotic formulations on PPAR a and PPAR- b / d expressions in mouse kidneyen_US
dc.typearticleen_US
dc.relation.ispartofBiotechnic and Histochemistryen_US
dc.departmentFakülteler, Veteriner Fakültesi, Temel Bilimler Bölümü, Histoloji ve Embriyoloji Ana Bilim Dalıen_US
dc.identifier.volume89en_US
dc.identifier.issue4en_US
dc.identifier.startpage287en_US
dc.identifier.endpage295en_US
dc.institutionauthorBakır, Buket
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid26640705000
dc.authorscopusid37121662100
dc.authorscopusid56577807500
dc.authorscopusid6701361197
dc.identifier.scopus2-s2.0-84921765709en_US
dc.identifier.pmid24205877en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster